Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Retinal Detachment | 32 | 2023 | 428 | 8.790 |
Why?
|
Macular Degeneration | 32 | 2024 | 1007 | 5.620 |
Why?
|
Retinal Pigment Epithelium | 18 | 2020 | 303 | 5.480 |
Why?
|
Photoreceptor Cells, Vertebrate | 16 | 2023 | 203 | 4.510 |
Why?
|
Tomography, Optical Coherence | 45 | 2024 | 2917 | 4.150 |
Why?
|
Retina | 33 | 2023 | 2659 | 3.740 |
Why?
|
Retinal Perforations | 9 | 2023 | 138 | 3.670 |
Why?
|
Fluorescein Angiography | 35 | 2024 | 1059 | 3.670 |
Why?
|
Visual Acuity | 47 | 2024 | 2672 | 3.620 |
Why?
|
Retinal Vessels | 19 | 2024 | 852 | 3.500 |
Why?
|
Aminoimidazole Carboxamide | 8 | 2020 | 85 | 3.370 |
Why?
|
Geographic Atrophy | 8 | 2024 | 91 | 3.310 |
Why?
|
Vitrectomy | 15 | 2024 | 392 | 3.200 |
Why?
|
Retinal Diseases | 15 | 2021 | 705 | 3.100 |
Why?
|
Receptor-Interacting Protein Serine-Threonine Kinases | 8 | 2023 | 140 | 2.580 |
Why?
|
Retinal Degeneration | 9 | 2023 | 413 | 2.570 |
Why?
|
Ribonucleotides | 8 | 2020 | 114 | 2.340 |
Why?
|
Epiretinal Membrane | 5 | 2023 | 73 | 2.190 |
Why?
|
Wet Macular Degeneration | 10 | 2024 | 162 | 2.150 |
Why?
|
Diabetic Retinopathy | 12 | 2024 | 1274 | 2.020 |
Why?
|
Cell Death | 13 | 2023 | 1678 | 1.820 |
Why?
|
Vitreous Detachment | 2 | 2023 | 22 | 1.750 |
Why?
|
Eye Injuries | 7 | 2023 | 227 | 1.630 |
Why?
|
Fundus Oculi | 19 | 2024 | 556 | 1.610 |
Why?
|
Burns, Chemical | 6 | 2024 | 123 | 1.590 |
Why?
|
Retinal Telangiectasis | 2 | 2022 | 25 | 1.530 |
Why?
|
Choroid | 9 | 2024 | 360 | 1.510 |
Why?
|
Macular Edema | 4 | 2023 | 374 | 1.460 |
Why?
|
Retinoblastoma | 4 | 2014 | 317 | 1.400 |
Why?
|
Scleral Buckling | 5 | 2020 | 95 | 1.400 |
Why?
|
AMP-Activated Protein Kinases | 7 | 2020 | 598 | 1.380 |
Why?
|
Vitreoretinopathy, Proliferative | 4 | 2017 | 76 | 1.370 |
Why?
|
Uveal Neoplasms | 4 | 2021 | 341 | 1.370 |
Why?
|
Lysosomal-Associated Membrane Protein 2 | 2 | 2019 | 53 | 1.360 |
Why?
|
Eye Burns | 4 | 2024 | 65 | 1.320 |
Why?
|
Photochemotherapy | 6 | 2021 | 823 | 1.320 |
Why?
|
Ribonucleosides | 2 | 2020 | 79 | 1.310 |
Why?
|
Inflammasomes | 4 | 2023 | 526 | 1.290 |
Why?
|
Retinal Hemorrhage | 3 | 2022 | 95 | 1.280 |
Why?
|
Necrosis | 7 | 2023 | 1611 | 1.240 |
Why?
|
Apoptosis | 23 | 2023 | 9486 | 1.220 |
Why?
|
Vascular Endothelial Growth Factor A | 20 | 2024 | 3492 | 1.210 |
Why?
|
Contrast Sensitivity | 8 | 2024 | 253 | 1.150 |
Why?
|
Electroretinography | 6 | 2024 | 525 | 1.110 |
Why?
|
Photosensitizing Agents | 6 | 2021 | 623 | 1.110 |
Why?
|
Photoreceptor Cells | 4 | 2023 | 236 | 1.090 |
Why?
|
Angiogenesis Inhibitors | 13 | 2024 | 2047 | 1.080 |
Why?
|
Phosphotransferases (Phosphate Group Acceptor) | 2 | 2017 | 18 | 1.060 |
Why?
|
Retinal Neovascularization | 7 | 2024 | 288 | 0.970 |
Why?
|
Retinal Neoplasms | 3 | 2017 | 146 | 0.960 |
Why?
|
Recombinant Fusion Proteins | 10 | 2022 | 3734 | 0.940 |
Why?
|
Night Blindness | 1 | 2024 | 56 | 0.930 |
Why?
|
Pentosan Sulfuric Polyester | 2 | 2019 | 9 | 0.910 |
Why?
|
Retinopathy of Prematurity | 3 | 2021 | 439 | 0.880 |
Why?
|
Subretinal Fluid | 3 | 2018 | 24 | 0.870 |
Why?
|
In Situ Nick-End Labeling | 11 | 2020 | 613 | 0.860 |
Why?
|
Codon, Nonsense | 1 | 2024 | 285 | 0.840 |
Why?
|
Carbonic Anhydrase Inhibitors | 2 | 2022 | 91 | 0.830 |
Why?
|
Macrophages | 9 | 2023 | 5769 | 0.820 |
Why?
|
Retinal Vein Occlusion | 5 | 2024 | 149 | 0.810 |
Why?
|
Toxoplasmosis, Ocular | 1 | 2022 | 29 | 0.810 |
Why?
|
Scotoma | 2 | 2023 | 130 | 0.790 |
Why?
|
Retinal Drusen | 5 | 2024 | 74 | 0.790 |
Why?
|
Oxidative Stress | 7 | 2021 | 3113 | 0.780 |
Why?
|
Facial Transplantation | 1 | 2024 | 221 | 0.770 |
Why?
|
Neovascularization, Pathologic | 4 | 2019 | 2645 | 0.770 |
Why?
|
Intravitreal Injections | 10 | 2024 | 385 | 0.770 |
Why?
|
Neuroprotective Agents | 4 | 2020 | 957 | 0.760 |
Why?
|
Phacoemulsification | 1 | 2023 | 149 | 0.760 |
Why?
|
Humans | 178 | 2024 | 761504 | 0.760 |
Why?
|
Disease Models, Animal | 25 | 2023 | 18252 | 0.750 |
Why?
|
Nicotinamide Mononucleotide | 1 | 2020 | 17 | 0.740 |
Why?
|
Gases | 1 | 2021 | 204 | 0.730 |
Why?
|
Cataract | 3 | 2023 | 832 | 0.710 |
Why?
|
Selenium | 1 | 2023 | 417 | 0.710 |
Why?
|
Altitude | 1 | 2021 | 163 | 0.710 |
Why?
|
Conjunctival Neoplasms | 1 | 2021 | 77 | 0.700 |
Why?
|
GTPase-Activating Proteins | 3 | 2019 | 471 | 0.700 |
Why?
|
Adaptor Proteins, Signal Transducing | 3 | 2021 | 2898 | 0.700 |
Why?
|
Melanoma | 5 | 2023 | 5709 | 0.690 |
Why?
|
Retinal Cone Photoreceptor Cells | 3 | 2024 | 184 | 0.690 |
Why?
|
Enzyme Activation | 8 | 2019 | 3597 | 0.690 |
Why?
|
Tumor Necrosis Factor-alpha | 14 | 2023 | 4352 | 0.690 |
Why?
|
Bruch Membrane | 3 | 2019 | 65 | 0.670 |
Why?
|
Receptors, Vascular Endothelial Growth Factor | 6 | 2022 | 664 | 0.670 |
Why?
|
Homozygote | 1 | 2024 | 1776 | 0.660 |
Why?
|
Endotamponade | 3 | 2019 | 37 | 0.660 |
Why?
|
Optic Disk | 3 | 2020 | 421 | 0.660 |
Why?
|
Cornea | 9 | 2024 | 1333 | 0.650 |
Why?
|
NF-kappa B | 4 | 2016 | 2490 | 0.640 |
Why?
|
Dark Adaptation | 5 | 2021 | 222 | 0.640 |
Why?
|
Complement C3 | 1 | 2020 | 435 | 0.640 |
Why?
|
Animals | 77 | 2023 | 168459 | 0.630 |
Why?
|
Basement Membrane | 1 | 2019 | 349 | 0.630 |
Why?
|
Blotting, Western | 12 | 2014 | 5035 | 0.630 |
Why?
|
Gene Expression Regulation, Neoplastic | 5 | 2021 | 8547 | 0.630 |
Why?
|
Choroidal Neovascularization | 8 | 2017 | 363 | 0.630 |
Why?
|
N-Methylaspartate | 1 | 2019 | 231 | 0.620 |
Why?
|
Cell Line | 13 | 2020 | 15601 | 0.600 |
Why?
|
Complement Factor B | 1 | 2017 | 57 | 0.600 |
Why?
|
Retinal Photoreceptor Cell Inner Segment | 1 | 2017 | 2 | 0.600 |
Why?
|
Neuroglia | 3 | 2018 | 956 | 0.590 |
Why?
|
Retinal Photoreceptor Cell Outer Segment | 1 | 2017 | 13 | 0.590 |
Why?
|
Spectrum Analysis | 1 | 2020 | 453 | 0.590 |
Why?
|
Coloboma | 1 | 2018 | 59 | 0.580 |
Why?
|
Bell Palsy | 1 | 2018 | 39 | 0.580 |
Why?
|
Macula Lutea | 3 | 2024 | 177 | 0.580 |
Why?
|
Antibodies | 2 | 2018 | 2418 | 0.580 |
Why?
|
Intraocular Pressure | 4 | 2021 | 1294 | 0.570 |
Why?
|
Reactive Oxygen Species | 5 | 2019 | 2141 | 0.570 |
Why?
|
Mice | 42 | 2023 | 81525 | 0.560 |
Why?
|
Eye Hemorrhage | 1 | 2016 | 19 | 0.560 |
Why?
|
Metabolomics | 7 | 2024 | 1659 | 0.560 |
Why?
|
Cholesterol | 2 | 2017 | 2904 | 0.550 |
Why?
|
Fluorocarbons | 2 | 2021 | 492 | 0.540 |
Why?
|
Eye Injuries, Penetrating | 3 | 2015 | 124 | 0.540 |
Why?
|
Hypertensive Retinopathy | 1 | 2016 | 4 | 0.540 |
Why?
|
Longevity | 1 | 2024 | 1065 | 0.540 |
Why?
|
Anterior Capsule of the Lens | 1 | 2015 | 3 | 0.530 |
Why?
|
Cell Cycle | 4 | 2019 | 2932 | 0.530 |
Why?
|
Interleukin-8 | 2 | 2017 | 695 | 0.520 |
Why?
|
Polyglactin 910 | 1 | 2016 | 55 | 0.520 |
Why?
|
Encephalocele | 1 | 2017 | 135 | 0.520 |
Why?
|
Retinitis | 1 | 2015 | 36 | 0.510 |
Why?
|
Biological Assay | 3 | 2021 | 626 | 0.510 |
Why?
|
Conjunctival Diseases | 1 | 2016 | 110 | 0.510 |
Why?
|
Iris Diseases | 1 | 2015 | 37 | 0.510 |
Why?
|
DNA, Neoplasm | 1 | 2021 | 1745 | 0.510 |
Why?
|
Receptors, Granulocyte-Macrophage Colony-Stimulating Factor | 3 | 2021 | 114 | 0.500 |
Why?
|
Panuveitis | 1 | 2015 | 33 | 0.500 |
Why?
|
Retinal Ganglion Cells | 6 | 2017 | 811 | 0.500 |
Why?
|
Microglia | 6 | 2021 | 1361 | 0.500 |
Why?
|
Leukemia, Promyelocytic, Acute | 1 | 2017 | 251 | 0.500 |
Why?
|
Fas Ligand Protein | 1 | 2015 | 216 | 0.490 |
Why?
|
Hemolytic-Uremic Syndrome | 1 | 2015 | 106 | 0.490 |
Why?
|
Uveitis | 2 | 2012 | 395 | 0.480 |
Why?
|
Pseudoxanthoma Elasticum | 1 | 2014 | 14 | 0.480 |
Why?
|
Uvea | 3 | 2017 | 30 | 0.480 |
Why?
|
Receptors, CCR2 | 1 | 2016 | 215 | 0.480 |
Why?
|
Silicone Oils | 1 | 2014 | 22 | 0.480 |
Why?
|
Adenylate Kinase | 2 | 2017 | 102 | 0.480 |
Why?
|
Eye Infections, Bacterial | 2 | 2015 | 242 | 0.470 |
Why?
|
Fibrinolysin | 2 | 2014 | 131 | 0.470 |
Why?
|
Albinism, Oculocutaneous | 1 | 2014 | 19 | 0.460 |
Why?
|
Polyglycolic Acid | 1 | 2016 | 406 | 0.460 |
Why?
|
Dyslipidemias | 1 | 2022 | 868 | 0.460 |
Why?
|
Scleritis | 1 | 2015 | 96 | 0.460 |
Why?
|
Emulsions | 1 | 2014 | 152 | 0.460 |
Why?
|
Mice, Inbred C57BL | 19 | 2021 | 22169 | 0.460 |
Why?
|
Pharmacogenetics | 1 | 2018 | 675 | 0.460 |
Why?
|
Retinoschisis | 4 | 2020 | 30 | 0.460 |
Why?
|
Choroid Diseases | 1 | 2014 | 63 | 0.450 |
Why?
|
Lipopolysaccharides | 4 | 2020 | 2206 | 0.450 |
Why?
|
Polyesters | 1 | 2016 | 373 | 0.450 |
Why?
|
Retinitis Pigmentosa | 3 | 2020 | 397 | 0.450 |
Why?
|
Choroiditis | 1 | 2013 | 12 | 0.450 |
Why?
|
Light | 2 | 2017 | 1353 | 0.440 |
Why?
|
Cell Proliferation | 8 | 2021 | 10445 | 0.440 |
Why?
|
Zinc | 1 | 2018 | 690 | 0.440 |
Why?
|
Dacryocystitis | 1 | 2014 | 68 | 0.440 |
Why?
|
Lens, Crystalline | 2 | 2008 | 389 | 0.440 |
Why?
|
Corneal Diseases | 5 | 2022 | 542 | 0.430 |
Why?
|
Caspases | 7 | 2019 | 879 | 0.430 |
Why?
|
Accidents, Traffic | 1 | 2019 | 816 | 0.430 |
Why?
|
Poly I-C | 1 | 2013 | 112 | 0.430 |
Why?
|
Peroxiredoxins | 1 | 2013 | 51 | 0.430 |
Why?
|
Smad7 Protein | 1 | 2013 | 39 | 0.430 |
Why?
|
Rod Opsins | 1 | 2013 | 108 | 0.430 |
Why?
|
Eye Foreign Bodies | 2 | 2015 | 52 | 0.420 |
Why?
|
Chorioretinitis | 1 | 2013 | 43 | 0.420 |
Why?
|
Hyaluronic Acid | 2 | 2013 | 483 | 0.420 |
Why?
|
Macrophage Activation | 1 | 2016 | 553 | 0.420 |
Why?
|
Syphilis | 1 | 2015 | 243 | 0.420 |
Why?
|
Porphyrins | 2 | 2014 | 352 | 0.420 |
Why?
|
Subarachnoid Hemorrhage | 1 | 2020 | 1033 | 0.410 |
Why?
|
Proto-Oncogene Proteins c-abl | 1 | 2013 | 140 | 0.410 |
Why?
|
Retinal Rod Photoreceptor Cells | 3 | 2024 | 204 | 0.410 |
Why?
|
Receptors, Pattern Recognition | 1 | 2013 | 83 | 0.410 |
Why?
|
Corneal Neovascularization | 4 | 2020 | 185 | 0.410 |
Why?
|
Refractive Errors | 1 | 2014 | 147 | 0.410 |
Why?
|
Male | 80 | 2024 | 360804 | 0.400 |
Why?
|
Interleukin-1beta | 6 | 2023 | 999 | 0.400 |
Why?
|
Graft Survival | 1 | 2023 | 3819 | 0.400 |
Why?
|
Uveitis, Anterior | 2 | 2017 | 102 | 0.400 |
Why?
|
RNA, Double-Stranded | 1 | 2013 | 294 | 0.390 |
Why?
|
Caspase 3 | 1 | 2014 | 731 | 0.390 |
Why?
|
Monocytes | 5 | 2023 | 2570 | 0.390 |
Why?
|
Taurochenodeoxycholic Acid | 1 | 2011 | 35 | 0.390 |
Why?
|
Caveolin 1 | 1 | 2013 | 256 | 0.380 |
Why?
|
Phosphoproteins | 2 | 2017 | 2448 | 0.380 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 1 | 2014 | 615 | 0.380 |
Why?
|
RNA, Neoplasm | 1 | 2014 | 750 | 0.380 |
Why?
|
Female | 71 | 2024 | 392644 | 0.380 |
Why?
|
Vitreous Body | 3 | 2024 | 399 | 0.370 |
Why?
|
Cost-Benefit Analysis | 1 | 2024 | 5492 | 0.370 |
Why?
|
Proteins | 2 | 2018 | 6032 | 0.370 |
Why?
|
Transcription Factors | 3 | 2021 | 12128 | 0.370 |
Why?
|
Cytokines | 5 | 2018 | 7396 | 0.360 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2021 | 2872 | 0.360 |
Why?
|
Vitreoretinal Surgery | 3 | 2017 | 28 | 0.360 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 9 | 2014 | 3810 | 0.360 |
Why?
|
Diagnostic Techniques, Ophthalmological | 3 | 2018 | 251 | 0.360 |
Why?
|
Infant, Premature | 1 | 2020 | 2107 | 0.360 |
Why?
|
Multiprotein Complexes | 1 | 2017 | 1118 | 0.360 |
Why?
|
Antioxidants | 2 | 2018 | 1668 | 0.360 |
Why?
|
Lactic Acid | 1 | 2016 | 1139 | 0.350 |
Why?
|
Metformin | 2 | 2017 | 906 | 0.350 |
Why?
|
Capillary Permeability | 2 | 2015 | 773 | 0.350 |
Why?
|
Myopia | 2 | 2024 | 253 | 0.350 |
Why?
|
Plasminogen Activators | 1 | 2010 | 199 | 0.350 |
Why?
|
Vision, Ocular | 1 | 2013 | 455 | 0.350 |
Why?
|
Vascular Malformations | 1 | 2015 | 468 | 0.350 |
Why?
|
Induced Pluripotent Stem Cells | 2 | 2019 | 1860 | 0.350 |
Why?
|
DNA, Mitochondrial | 1 | 2015 | 865 | 0.350 |
Why?
|
Polyethylene Glycols | 1 | 2016 | 1189 | 0.340 |
Why?
|
Radiotherapy, High-Energy | 1 | 2010 | 228 | 0.340 |
Why?
|
Capillary Leak Syndrome | 1 | 2009 | 34 | 0.340 |
Why?
|
Diabetes Mellitus, Type 2 | 3 | 2024 | 12148 | 0.340 |
Why?
|
Up-Regulation | 1 | 2019 | 4124 | 0.340 |
Why?
|
Inflammation | 5 | 2017 | 10773 | 0.340 |
Why?
|
Uveal Diseases | 1 | 2009 | 45 | 0.340 |
Why?
|
Autophagy | 5 | 2022 | 1326 | 0.340 |
Why?
|
Blood-Retinal Barrier | 1 | 2009 | 62 | 0.330 |
Why?
|
Integrases | 1 | 2012 | 516 | 0.330 |
Why?
|
Software | 2 | 2020 | 4434 | 0.330 |
Why?
|
Drug Delivery Systems | 3 | 2020 | 2226 | 0.330 |
Why?
|
Salmonella typhimurium | 1 | 2011 | 347 | 0.320 |
Why?
|
Blister | 1 | 2009 | 86 | 0.320 |
Why?
|
Interleukin-6 | 2 | 2017 | 3208 | 0.320 |
Why?
|
Enzymes | 1 | 2010 | 257 | 0.320 |
Why?
|
Serum Albumin, Bovine | 1 | 2009 | 321 | 0.320 |
Why?
|
Low Tension Glaucoma | 1 | 2008 | 24 | 0.320 |
Why?
|
Endocytosis | 1 | 2013 | 957 | 0.320 |
Why?
|
Optics and Photonics | 1 | 2010 | 306 | 0.320 |
Why?
|
Lens Subluxation | 1 | 2008 | 23 | 0.310 |
Why?
|
Mice, Knockout | 9 | 2019 | 14414 | 0.310 |
Why?
|
Retinal Artery | 1 | 2009 | 109 | 0.310 |
Why?
|
Phosphorylation | 9 | 2020 | 8320 | 0.310 |
Why?
|
Atrophy | 4 | 2023 | 1633 | 0.310 |
Why?
|
Protein Carbonylation | 3 | 2020 | 28 | 0.310 |
Why?
|
Glaucoma | 5 | 2023 | 1185 | 0.310 |
Why?
|
TOR Serine-Threonine Kinases | 2 | 2014 | 2057 | 0.310 |
Why?
|
Aged | 44 | 2024 | 169289 | 0.300 |
Why?
|
RNA, Messenger | 5 | 2019 | 12795 | 0.300 |
Why?
|
Proto-Oncogene Proteins c-akt | 2 | 2014 | 2455 | 0.300 |
Why?
|
Epilepsy | 1 | 2023 | 3290 | 0.300 |
Why?
|
Matrix Metalloproteinase 9 | 1 | 2011 | 632 | 0.290 |
Why?
|
Gene Expression Regulation, Enzymologic | 2 | 2016 | 1171 | 0.290 |
Why?
|
Polysaccharides | 1 | 2014 | 1014 | 0.290 |
Why?
|
Endothelial Cells | 5 | 2016 | 3548 | 0.290 |
Why?
|
Complement Activation | 2 | 2020 | 445 | 0.290 |
Why?
|
Eye Diseases | 2 | 2022 | 653 | 0.280 |
Why?
|
Ischemia | 1 | 2016 | 1882 | 0.280 |
Why?
|
Middle Aged | 44 | 2024 | 220895 | 0.280 |
Why?
|
Anti-Mullerian Hormone | 1 | 2009 | 407 | 0.280 |
Why?
|
Neovascularization, Physiologic | 1 | 2014 | 1349 | 0.270 |
Why?
|
Image Processing, Computer-Assisted | 2 | 2020 | 9000 | 0.270 |
Why?
|
Inflammation Mediators | 2 | 2018 | 1886 | 0.270 |
Why?
|
Anticoagulants | 2 | 2019 | 4812 | 0.270 |
Why?
|
Aging | 3 | 2024 | 8708 | 0.270 |
Why?
|
Fovea Centralis | 3 | 2020 | 126 | 0.270 |
Why?
|
Immunity, Cellular | 1 | 2012 | 1560 | 0.270 |
Why?
|
Tubercidin | 2 | 2017 | 15 | 0.260 |
Why?
|
Retinal Dystrophies | 2 | 2020 | 65 | 0.260 |
Why?
|
Rats, Inbred BN | 5 | 2016 | 231 | 0.260 |
Why?
|
Aneurysm | 1 | 2009 | 337 | 0.260 |
Why?
|
DNA-Binding Proteins | 4 | 2017 | 9606 | 0.260 |
Why?
|
Hypoglycemic Agents | 4 | 2024 | 3085 | 0.260 |
Why?
|
Nuclear Proteins | 2 | 2017 | 5796 | 0.260 |
Why?
|
Eye Diseases, Hereditary | 2 | 2024 | 122 | 0.260 |
Why?
|
Myopia, Degenerative | 2 | 2015 | 15 | 0.260 |
Why?
|
Dipyridamole | 2 | 2017 | 140 | 0.260 |
Why?
|
Disease Progression | 6 | 2024 | 13506 | 0.250 |
Why?
|
Injections, Intraperitoneal | 4 | 2018 | 413 | 0.250 |
Why?
|
Diagnostic Imaging | 1 | 2020 | 3530 | 0.250 |
Why?
|
Calcium-Binding Proteins | 2 | 2024 | 1069 | 0.250 |
Why?
|
Follow-Up Studies | 15 | 2024 | 39106 | 0.250 |
Why?
|
Aptamers, Nucleotide | 1 | 2006 | 165 | 0.250 |
Why?
|
Embryo, Mammalian | 1 | 2011 | 1675 | 0.240 |
Why?
|
Conjunctiva | 1 | 2008 | 479 | 0.240 |
Why?
|
Ophthalmoscopy | 2 | 2018 | 171 | 0.240 |
Why?
|
Phagocytosis | 3 | 2020 | 1528 | 0.240 |
Why?
|
Hydroxychloroquine | 1 | 2008 | 426 | 0.230 |
Why?
|
Boric Acids | 1 | 2004 | 5 | 0.230 |
Why?
|
Lipids | 4 | 2022 | 3341 | 0.230 |
Why?
|
Thimerosal | 1 | 2004 | 15 | 0.230 |
Why?
|
Photophobia | 1 | 2024 | 75 | 0.230 |
Why?
|
Prostheses and Implants | 4 | 2024 | 1271 | 0.220 |
Why?
|
Prospective Studies | 20 | 2024 | 54425 | 0.220 |
Why?
|
Lymphangioma | 1 | 2004 | 61 | 0.220 |
Why?
|
Glucocorticoids | 3 | 2015 | 2161 | 0.220 |
Why?
|
Gene Expression Regulation | 6 | 2016 | 11903 | 0.220 |
Why?
|
Microtubule-Associated Proteins | 2 | 2020 | 1076 | 0.220 |
Why?
|
Cells, Cultured | 7 | 2020 | 18965 | 0.220 |
Why?
|
Skin Neoplasms | 1 | 2023 | 5821 | 0.220 |
Why?
|
Adult | 27 | 2024 | 221177 | 0.210 |
Why?
|
Phenylephrine | 1 | 2004 | 293 | 0.210 |
Why?
|
Retrospective Studies | 24 | 2024 | 80636 | 0.210 |
Why?
|
Traction | 1 | 2023 | 110 | 0.210 |
Why?
|
Anti-Inflammatory Agents | 2 | 2018 | 1809 | 0.210 |
Why?
|
Organic Chemicals | 2 | 2021 | 210 | 0.210 |
Why?
|
Iris | 1 | 2004 | 232 | 0.210 |
Why?
|
Malonyl Coenzyme A | 6 | 2000 | 19 | 0.210 |
Why?
|
Acetyl-CoA Carboxylase | 4 | 2000 | 72 | 0.210 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3084 | 0.210 |
Why?
|
Iron | 2 | 2023 | 1793 | 0.210 |
Why?
|
Gene Knockdown Techniques | 2 | 2019 | 1612 | 0.200 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3204 | 0.200 |
Why?
|
Ophthalmic Solutions | 1 | 2004 | 313 | 0.200 |
Why?
|
Rats | 16 | 2016 | 23742 | 0.200 |
Why?
|
Laser Coagulation | 2 | 2017 | 330 | 0.200 |
Why?
|
Cell Line, Tumor | 5 | 2021 | 16981 | 0.200 |
Why?
|
Lysosomes | 4 | 2022 | 924 | 0.200 |
Why?
|
Cell Survival | 8 | 2018 | 5791 | 0.200 |
Why?
|
Circadian Rhythm | 1 | 2013 | 2576 | 0.200 |
Why?
|
Apoptosis Inducing Factor | 2 | 2012 | 51 | 0.190 |
Why?
|
Orbital Neoplasms | 1 | 2004 | 222 | 0.190 |
Why?
|
Diagnosis, Differential | 5 | 2021 | 12974 | 0.190 |
Why?
|
Oxygen | 1 | 2013 | 4227 | 0.190 |
Why?
|
Cross-Sectional Studies | 18 | 2024 | 26125 | 0.190 |
Why?
|
Neurodegenerative Diseases | 2 | 2021 | 1087 | 0.180 |
Why?
|
Retinal Pigments | 1 | 2020 | 83 | 0.180 |
Why?
|
Aged, 80 and over | 19 | 2024 | 58976 | 0.180 |
Why?
|
Vitreous Hemorrhage | 1 | 2021 | 48 | 0.180 |
Why?
|
Mitochondria | 3 | 2023 | 3624 | 0.180 |
Why?
|
Arteriovenous Malformations | 1 | 2004 | 396 | 0.180 |
Why?
|
Ciliary Body | 2 | 2021 | 167 | 0.180 |
Why?
|
Aircraft | 1 | 2021 | 130 | 0.180 |
Why?
|
Fibroblasts | 1 | 2011 | 4141 | 0.180 |
Why?
|
Indoles | 2 | 2019 | 1833 | 0.180 |
Why?
|
Genetic Diseases, X-Linked | 1 | 2024 | 386 | 0.180 |
Why?
|
Tail | 1 | 2020 | 91 | 0.170 |
Why?
|
Pandemics | 1 | 2020 | 8654 | 0.170 |
Why?
|
Autoimmune Diseases | 1 | 2012 | 2244 | 0.170 |
Why?
|
Optic Nerve | 1 | 2023 | 572 | 0.170 |
Why?
|
Oligopeptides | 2 | 2019 | 1187 | 0.170 |
Why?
|
Imidazoles | 2 | 2019 | 1180 | 0.170 |
Why?
|
Image Enhancement | 1 | 2010 | 2885 | 0.170 |
Why?
|
Sirtuin 1 | 1 | 2020 | 246 | 0.170 |
Why?
|
Proteomics | 2 | 2024 | 3849 | 0.160 |
Why?
|
Fatty Acids, Monounsaturated | 1 | 2020 | 190 | 0.160 |
Why?
|
Lasers | 3 | 2019 | 952 | 0.160 |
Why?
|
Rabbits | 6 | 2023 | 4772 | 0.160 |
Why?
|
Glial Fibrillary Acidic Protein | 1 | 2020 | 553 | 0.160 |
Why?
|
Chemokine CCL2 | 2 | 2011 | 605 | 0.160 |
Why?
|
ras Proteins | 3 | 2001 | 1054 | 0.160 |
Why?
|
Infant, Newborn | 6 | 2024 | 26198 | 0.160 |
Why?
|
Protein Kinases | 2 | 2014 | 1608 | 0.150 |
Why?
|
Organosilicon Compounds | 1 | 2017 | 4 | 0.150 |
Why?
|
Heme Oxygenase-1 | 1 | 2020 | 366 | 0.150 |
Why?
|
Exocytosis | 1 | 2019 | 320 | 0.150 |
Why?
|
Adjuvants, Immunologic | 1 | 2004 | 1036 | 0.150 |
Why?
|
Laminin | 1 | 2019 | 408 | 0.150 |
Why?
|
Adolescent | 11 | 2022 | 88319 | 0.150 |
Why?
|
Mitochondrial Diseases | 1 | 2021 | 343 | 0.150 |
Why?
|
Contact Lenses | 1 | 2019 | 138 | 0.150 |
Why?
|
Cysteine-Rich Protein 61 | 1 | 2017 | 37 | 0.150 |
Why?
|
Visual Fields | 2 | 2019 | 1062 | 0.150 |
Why?
|
Drug Combinations | 2 | 2019 | 2048 | 0.150 |
Why?
|
Complement Factor H | 1 | 2018 | 110 | 0.150 |
Why?
|
Mice, Inbred BALB C | 3 | 2015 | 6216 | 0.140 |
Why?
|
Optic Nerve Injuries | 1 | 2018 | 150 | 0.140 |
Why?
|
Alu Elements | 1 | 2018 | 115 | 0.140 |
Why?
|
Fibroblast Growth Factor 2 | 1 | 2019 | 592 | 0.140 |
Why?
|
Connective Tissue Growth Factor | 1 | 2017 | 92 | 0.140 |
Why?
|
Receptors, Tumor Necrosis Factor, Type II | 3 | 2017 | 344 | 0.140 |
Why?
|
Dehydroepiandrosterone | 1 | 2018 | 258 | 0.140 |
Why?
|
Vision Disorders | 2 | 2019 | 1088 | 0.140 |
Why?
|
Fluorescent Antibody Technique | 1 | 2021 | 2469 | 0.140 |
Why?
|
Body Fluids | 1 | 2019 | 320 | 0.140 |
Why?
|
Signal Transduction | 9 | 2017 | 23445 | 0.140 |
Why?
|
Glutathione | 1 | 2019 | 583 | 0.140 |
Why?
|
NAD | 1 | 2020 | 614 | 0.140 |
Why?
|
Fatty Acids, Unsaturated | 1 | 2020 | 540 | 0.140 |
Why?
|
Activin Receptors, Type II | 1 | 2017 | 123 | 0.140 |
Why?
|
Pedigree | 1 | 2024 | 4542 | 0.140 |
Why?
|
Glutamine | 1 | 2019 | 577 | 0.140 |
Why?
|
Visual Field Tests | 1 | 2019 | 411 | 0.130 |
Why?
|
Octamer Transcription Factor-3 | 1 | 2017 | 223 | 0.130 |
Why?
|
Proteoglycans | 1 | 2019 | 803 | 0.130 |
Why?
|
Mice, Mutant Strains | 3 | 2018 | 1749 | 0.130 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 3 | 2012 | 4575 | 0.130 |
Why?
|
Models, Animal | 2 | 2019 | 2112 | 0.130 |
Why?
|
Blood Cell Count | 1 | 2017 | 397 | 0.130 |
Why?
|
Autoanalysis | 1 | 2015 | 71 | 0.130 |
Why?
|
Penicillin G | 1 | 2015 | 40 | 0.130 |
Why?
|
RNA Interference | 2 | 2016 | 2831 | 0.130 |
Why?
|
Adenosine | 1 | 2020 | 808 | 0.130 |
Why?
|
Microscopy, Acoustic | 1 | 2015 | 47 | 0.130 |
Why?
|
Ribonuclease III | 1 | 2018 | 279 | 0.130 |
Why?
|
Syphilis Serodiagnosis | 1 | 2015 | 37 | 0.130 |
Why?
|
Antibody Specificity | 1 | 2018 | 1060 | 0.130 |
Why?
|
Lipid Metabolism | 2 | 2022 | 1902 | 0.130 |
Why?
|
Artificial Organs | 1 | 2017 | 150 | 0.130 |
Why?
|
Antigens, Differentiation, Myelomonocytic | 2 | 2020 | 283 | 0.130 |
Why?
|
Transplantation, Homologous | 1 | 2024 | 4806 | 0.130 |
Why?
|
Pharmaceutical Preparations | 1 | 2004 | 1089 | 0.130 |
Why?
|
Axons | 1 | 2023 | 1674 | 0.130 |
Why?
|
Postoperative Complications | 1 | 2017 | 15631 | 0.120 |
Why?
|
Complement Pathway, Alternative | 1 | 2015 | 113 | 0.120 |
Why?
|
Cytarabine | 1 | 2017 | 697 | 0.120 |
Why?
|
Optic Neuropathy, Ischemic | 1 | 2016 | 86 | 0.120 |
Why?
|
Metabolic Diseases | 1 | 2021 | 683 | 0.120 |
Why?
|
DEAD-box RNA Helicases | 1 | 2018 | 384 | 0.120 |
Why?
|
Eye Pain | 1 | 2015 | 46 | 0.120 |
Why?
|
Muscle, Skeletal | 7 | 2000 | 4948 | 0.120 |
Why?
|
Cysteine | 1 | 2019 | 891 | 0.120 |
Why?
|
Time Factors | 6 | 2021 | 39967 | 0.120 |
Why?
|
Rod Cell Outer Segment | 1 | 2014 | 51 | 0.120 |
Why?
|
T-Lymphocytes | 1 | 2012 | 10194 | 0.120 |
Why?
|
Collagen | 2 | 2020 | 2638 | 0.120 |
Why?
|
Flow Cytometry | 3 | 2014 | 5869 | 0.120 |
Why?
|
Hematopoiesis | 2 | 2021 | 2049 | 0.120 |
Why?
|
p38 Mitogen-Activated Protein Kinases | 1 | 2017 | 687 | 0.120 |
Why?
|
Infant | 6 | 2022 | 36192 | 0.110 |
Why?
|
Drug Substitution | 2 | 2015 | 290 | 0.110 |
Why?
|
Tretinoin | 1 | 2017 | 519 | 0.110 |
Why?
|
Lipoproteins, LDL | 1 | 2017 | 642 | 0.110 |
Why?
|
Recovery of Function | 1 | 2024 | 2979 | 0.110 |
Why?
|
Neuropilin-1 | 1 | 2014 | 90 | 0.110 |
Why?
|
Multienzyme Complexes | 1 | 1997 | 666 | 0.110 |
Why?
|
Glucose | 2 | 2023 | 4346 | 0.110 |
Why?
|
Dexamethasone | 2 | 2019 | 1948 | 0.110 |
Why?
|
Brain | 1 | 2020 | 27112 | 0.110 |
Why?
|
GTP-Binding Proteins | 1 | 1998 | 951 | 0.110 |
Why?
|
Tissue Donors | 1 | 2023 | 2331 | 0.110 |
Why?
|
Crystallization | 1 | 2014 | 534 | 0.110 |
Why?
|
Antimetabolites, Antineoplastic | 1 | 2017 | 646 | 0.110 |
Why?
|
Remission, Spontaneous | 1 | 2014 | 384 | 0.110 |
Why?
|
Small Molecule Libraries | 1 | 2018 | 733 | 0.110 |
Why?
|
Postoperative Hemorrhage | 1 | 2017 | 415 | 0.110 |
Why?
|
Food, Fortified | 1 | 2014 | 190 | 0.110 |
Why?
|
Xenograft Model Antitumor Assays | 3 | 2017 | 3602 | 0.110 |
Why?
|
Cyclic Nucleotide Phosphodiesterases, Type 6 | 1 | 2012 | 27 | 0.100 |
Why?
|
Class Ib Phosphatidylinositol 3-Kinase | 1 | 2013 | 43 | 0.100 |
Why?
|
Suprachiasmatic Nucleus | 1 | 2013 | 140 | 0.100 |
Why?
|
Treatment Outcome | 9 | 2019 | 64680 | 0.100 |
Why?
|
Oxidants | 1 | 2013 | 169 | 0.100 |
Why?
|
Blood Loss, Surgical | 1 | 2017 | 637 | 0.100 |
Why?
|
Platelet Transfusion | 1 | 2015 | 297 | 0.100 |
Why?
|
Daunorubicin | 1 | 2012 | 156 | 0.100 |
Why?
|
Antineoplastic Agents | 2 | 2013 | 13639 | 0.100 |
Why?
|
Portugal | 2 | 2024 | 91 | 0.100 |
Why?
|
Muscle Contraction | 1 | 1997 | 1201 | 0.100 |
Why?
|
Melanocytes | 1 | 2015 | 509 | 0.100 |
Why?
|
Oncolytic Virotherapy | 1 | 2017 | 516 | 0.100 |
Why?
|
Proto-Oncogene Proteins c-myc | 1 | 2017 | 988 | 0.100 |
Why?
|
Cytochrome P-450 Enzyme System | 1 | 2014 | 412 | 0.100 |
Why?
|
Cataract Extraction | 1 | 2016 | 467 | 0.100 |
Why?
|
S Phase | 1 | 2013 | 421 | 0.100 |
Why?
|
Sulfones | 1 | 2014 | 448 | 0.100 |
Why?
|
Papillomaviridae | 1 | 2017 | 1119 | 0.100 |
Why?
|
Gestational Age | 1 | 2020 | 3577 | 0.100 |
Why?
|
Antipyrine | 1 | 2011 | 40 | 0.100 |
Why?
|
Cell Count | 1 | 2015 | 1835 | 0.090 |
Why?
|
Vascular Endothelial Growth Factor Receptor-2 | 1 | 2014 | 546 | 0.090 |
Why?
|
Enzyme Activators | 1 | 2011 | 57 | 0.090 |
Why?
|
Infrared Rays | 1 | 2012 | 247 | 0.090 |
Why?
|
Isotretinoin | 1 | 2012 | 134 | 0.090 |
Why?
|
Chondroitinases and Chondroitin Lyases | 1 | 2010 | 15 | 0.090 |
Why?
|
Receptor Protein-Tyrosine Kinases | 2 | 2017 | 1626 | 0.090 |
Why?
|
Neutrophils | 1 | 2023 | 3767 | 0.090 |
Why?
|
Aqueous Humor | 1 | 2011 | 153 | 0.090 |
Why?
|
Anterior Chamber | 1 | 2011 | 194 | 0.090 |
Why?
|
Hyperlipidemias | 1 | 2016 | 771 | 0.090 |
Why?
|
Optic Nerve Diseases | 1 | 2014 | 342 | 0.090 |
Why?
|
Integrin alphaVbeta3 | 1 | 2011 | 105 | 0.090 |
Why?
|
Mice, Nude | 2 | 2017 | 3615 | 0.090 |
Why?
|
Receptor, Platelet-Derived Growth Factor alpha | 1 | 2012 | 368 | 0.090 |
Why?
|
Cyclins | 1 | 2013 | 594 | 0.090 |
Why?
|
Microscopy, Electron, Transmission | 1 | 2012 | 695 | 0.090 |
Why?
|
Heparin, Low-Molecular-Weight | 1 | 2012 | 344 | 0.090 |
Why?
|
Albumins | 1 | 2013 | 575 | 0.090 |
Why?
|
Subtilisins | 1 | 2010 | 81 | 0.090 |
Why?
|
Seizures | 1 | 2023 | 2957 | 0.090 |
Why?
|
I-kappa B Proteins | 1 | 2011 | 211 | 0.090 |
Why?
|
Free Radical Scavengers | 1 | 2011 | 211 | 0.090 |
Why?
|
Hyaluronoglucosaminidase | 1 | 2010 | 136 | 0.090 |
Why?
|
Gene Deletion | 1 | 2018 | 2665 | 0.090 |
Why?
|
Collagenases | 1 | 2010 | 222 | 0.090 |
Why?
|
Disease Management | 1 | 2020 | 2508 | 0.090 |
Why?
|
Peptide Fragments | 2 | 2014 | 5112 | 0.090 |
Why?
|
Oxidation-Reduction | 2 | 2017 | 2231 | 0.080 |
Why?
|
Receptors, Tumor Necrosis Factor | 1 | 2012 | 585 | 0.080 |
Why?
|
Oxidoreductases | 1 | 2012 | 413 | 0.080 |
Why?
|
Hydrogen Peroxide | 1 | 2013 | 730 | 0.080 |
Why?
|
Tamoxifen | 1 | 2014 | 965 | 0.080 |
Why?
|
Rats, Inbred Lew | 1 | 2011 | 1157 | 0.080 |
Why?
|
Young Adult | 7 | 2024 | 59243 | 0.080 |
Why?
|
Eye | 2 | 2015 | 712 | 0.080 |
Why?
|
Prognosis | 4 | 2015 | 29625 | 0.080 |
Why?
|
Biotinylation | 1 | 2009 | 184 | 0.080 |
Why?
|
CD4 Lymphocyte Count | 1 | 2015 | 2571 | 0.080 |
Why?
|
Antigens, CD | 3 | 2020 | 4003 | 0.080 |
Why?
|
Triamcinolone | 1 | 2009 | 68 | 0.080 |
Why?
|
Nitriles | 1 | 2014 | 971 | 0.080 |
Why?
|
Quinoxalines | 1 | 2011 | 296 | 0.080 |
Why?
|
Neoplasm Transplantation | 1 | 2013 | 2016 | 0.080 |
Why?
|
HSP70 Heat-Shock Proteins | 1 | 2011 | 397 | 0.080 |
Why?
|
Microvessels | 2 | 2024 | 577 | 0.080 |
Why?
|
Microscopy, Electron | 1 | 2012 | 2561 | 0.080 |
Why?
|
Isoenzymes | 1 | 2013 | 1687 | 0.080 |
Why?
|
Telangiectasis | 1 | 2008 | 78 | 0.080 |
Why?
|
Dose-Response Relationship, Drug | 3 | 2019 | 10766 | 0.080 |
Why?
|
Microscopy, Fluorescence | 1 | 2015 | 2645 | 0.080 |
Why?
|
Protein Binding | 4 | 2013 | 9351 | 0.080 |
Why?
|
Magnetic Resonance Imaging | 5 | 2020 | 36426 | 0.080 |
Why?
|
Lupus Erythematosus, Discoid | 1 | 2008 | 61 | 0.080 |
Why?
|
Citric Acid | 2 | 1999 | 123 | 0.070 |
Why?
|
Neoplasms | 1 | 2017 | 22170 | 0.070 |
Why?
|
DNA Primers | 1 | 2012 | 2819 | 0.070 |
Why?
|
Proto-Oncogene Proteins | 2 | 2017 | 4511 | 0.070 |
Why?
|
HEK293 Cells | 1 | 2017 | 4278 | 0.070 |
Why?
|
Intercellular Adhesion Molecule-1 | 1 | 2011 | 1126 | 0.070 |
Why?
|
Fluorouracil | 1 | 2012 | 1641 | 0.070 |
Why?
|
Organ Size | 1 | 2012 | 2254 | 0.070 |
Why?
|
Immunoprecipitation | 1 | 2009 | 878 | 0.070 |
Why?
|
Microscopy, Confocal | 1 | 2013 | 1971 | 0.070 |
Why?
|
Child | 7 | 2022 | 80153 | 0.070 |
Why?
|
Risk Factors | 7 | 2018 | 74206 | 0.070 |
Why?
|
Antiretroviral Therapy, Highly Active | 1 | 2015 | 1897 | 0.070 |
Why?
|
Pluripotent Stem Cells | 1 | 2014 | 799 | 0.070 |
Why?
|
Wounds, Gunshot | 1 | 2013 | 582 | 0.070 |
Why?
|
Metabolome | 2 | 2024 | 989 | 0.070 |
Why?
|
Statistics, Nonparametric | 1 | 2012 | 2850 | 0.070 |
Why?
|
Endopeptidases | 1 | 2010 | 774 | 0.070 |
Why?
|
RNA, Small Interfering | 1 | 2016 | 3429 | 0.070 |
Why?
|
Ultrasonography | 2 | 2014 | 5972 | 0.070 |
Why?
|
Tumor Cells, Cultured | 1 | 2014 | 6132 | 0.070 |
Why?
|
Neoplasm Staging | 1 | 2021 | 11121 | 0.070 |
Why?
|
Sodium Hydroxide | 2 | 2017 | 37 | 0.070 |
Why?
|
Europe | 1 | 2013 | 3422 | 0.070 |
Why?
|
Endophthalmitis | 1 | 2009 | 260 | 0.070 |
Why?
|
Gene Frequency | 1 | 2013 | 3606 | 0.060 |
Why?
|
Renal Dialysis | 1 | 2015 | 1797 | 0.060 |
Why?
|
Benzamides | 1 | 2011 | 1370 | 0.060 |
Why?
|
Nerve Tissue Proteins | 1 | 1998 | 4414 | 0.060 |
Why?
|
Epithelial Cells | 1 | 2017 | 3673 | 0.060 |
Why?
|
Protons | 1 | 2010 | 1116 | 0.060 |
Why?
|
Chronic Disease | 3 | 2018 | 9318 | 0.060 |
Why?
|
Antibodies, Monoclonal | 2 | 2014 | 9177 | 0.060 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 2017 | 2751 | 0.060 |
Why?
|
Fatty Acids, Omega-3 | 1 | 2014 | 1390 | 0.060 |
Why?
|
Fibrinolytic Agents | 1 | 2014 | 2084 | 0.060 |
Why?
|
Nanoparticles | 1 | 2016 | 1959 | 0.060 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2014 | 2273 | 0.060 |
Why?
|
Recurrence | 2 | 2013 | 8465 | 0.060 |
Why?
|
Hemangioma | 1 | 2009 | 727 | 0.060 |
Why?
|
Genome-Wide Association Study | 1 | 2023 | 12690 | 0.060 |
Why?
|
Membrane Proteins | 1 | 2020 | 7856 | 0.060 |
Why?
|
Analysis of Variance | 1 | 2012 | 6228 | 0.060 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2014 | 2917 | 0.060 |
Why?
|
Suture Techniques | 1 | 2008 | 769 | 0.060 |
Why?
|
Thiazoles | 1 | 2011 | 1517 | 0.050 |
Why?
|
Receptors, Tumor Necrosis Factor, Type I | 2 | 2017 | 256 | 0.050 |
Why?
|
Stress, Physiological | 1 | 2011 | 1403 | 0.050 |
Why?
|
Genotype | 2 | 2020 | 12990 | 0.050 |
Why?
|
Diabetes Mellitus, Experimental | 1 | 2009 | 1119 | 0.050 |
Why?
|
Carrier Proteins | 2 | 2015 | 4936 | 0.050 |
Why?
|
Amino Acid Sequence | 2 | 2009 | 13446 | 0.050 |
Why?
|
Sickness Impact Profile | 1 | 2024 | 299 | 0.050 |
Why?
|
Decision Making | 1 | 2017 | 3929 | 0.050 |
Why?
|
Proto-Oncogene Proteins c-raf | 2 | 2001 | 205 | 0.050 |
Why?
|
Quality of Life | 1 | 2024 | 13367 | 0.050 |
Why?
|
Diabetes Mellitus | 1 | 2020 | 5840 | 0.050 |
Why?
|
Molecular Sequence Data | 2 | 2009 | 17635 | 0.050 |
Why?
|
Case-Control Studies | 3 | 2019 | 22176 | 0.050 |
Why?
|
Capillaries | 1 | 2024 | 755 | 0.050 |
Why?
|
Membrane Glycoproteins | 1 | 2012 | 3702 | 0.050 |
Why?
|
Carnitine | 1 | 2022 | 252 | 0.050 |
Why?
|
Hydrogen-Ion Concentration | 2 | 2017 | 2496 | 0.050 |
Why?
|
Regional Blood Flow | 1 | 2024 | 1496 | 0.050 |
Why?
|
Needles | 1 | 2024 | 451 | 0.050 |
Why?
|
Cell Differentiation | 2 | 2018 | 11528 | 0.040 |
Why?
|
Drug Administration Schedule | 1 | 2008 | 4853 | 0.040 |
Why?
|
Immunohistochemistry | 1 | 2014 | 11076 | 0.040 |
Why?
|
Fluorescent Antibody Technique, Indirect | 2 | 2011 | 427 | 0.040 |
Why?
|
Equipment Design | 1 | 2008 | 3510 | 0.040 |
Why?
|
Alzheimer Disease | 1 | 2022 | 8599 | 0.040 |
Why?
|
Receptors, Chemokine | 1 | 2023 | 652 | 0.040 |
Why?
|
Leber Congenital Amaurosis | 1 | 2020 | 36 | 0.040 |
Why?
|
Immunoglobulin G | 1 | 2012 | 4544 | 0.040 |
Why?
|
MicroRNAs | 1 | 2016 | 3816 | 0.040 |
Why?
|
Guanosine Triphosphate | 2 | 1998 | 316 | 0.040 |
Why?
|
Riboflavin | 1 | 2020 | 107 | 0.040 |
Why?
|
Enzyme Inhibitors | 1 | 2010 | 3712 | 0.040 |
Why?
|
Longitudinal Studies | 3 | 2024 | 14605 | 0.040 |
Why?
|
Insulin Resistance | 3 | 1999 | 3963 | 0.040 |
Why?
|
Atherosclerosis | 1 | 2016 | 3408 | 0.040 |
Why?
|
Posterior Eye Segment | 1 | 2019 | 17 | 0.040 |
Why?
|
Feasibility Studies | 2 | 2024 | 5247 | 0.040 |
Why?
|
Mice, Transgenic | 1 | 2012 | 9539 | 0.040 |
Why?
|
Models, Biological | 3 | 2011 | 9469 | 0.040 |
Why?
|
Phenotype | 2 | 2020 | 16591 | 0.040 |
Why?
|
Reference Values | 2 | 2024 | 4920 | 0.040 |
Why?
|
Energy Metabolism | 2 | 2021 | 2882 | 0.040 |
Why?
|
Anti-Bacterial Agents | 2 | 2015 | 7407 | 0.040 |
Why?
|
Algorithms | 1 | 2019 | 14031 | 0.040 |
Why?
|
Vascular Endothelial Growth Factors | 1 | 2020 | 748 | 0.040 |
Why?
|
Dietary Fats, Unsaturated | 1 | 2020 | 224 | 0.040 |
Why?
|
Angiography | 1 | 2023 | 1595 | 0.040 |
Why?
|
Magnetic Resonance Spectroscopy | 2 | 2019 | 3769 | 0.040 |
Why?
|
Prosthesis Implantation | 1 | 2022 | 592 | 0.040 |
Why?
|
Lipid Peroxidation | 1 | 2018 | 271 | 0.040 |
Why?
|
Smad5 Protein | 1 | 2017 | 26 | 0.040 |
Why?
|
Physical Exertion | 1 | 2000 | 667 | 0.040 |
Why?
|
Receptor, trkA | 1 | 2018 | 159 | 0.040 |
Why?
|
Receptors, Steroid | 1 | 1998 | 156 | 0.040 |
Why?
|
Alkalies | 1 | 2017 | 44 | 0.040 |
Why?
|
Growth Differentiation Factor 2 | 1 | 2017 | 27 | 0.040 |
Why?
|
Peptides | 1 | 2009 | 4358 | 0.040 |
Why?
|
Receptors, Thyroid Hormone | 1 | 1998 | 199 | 0.040 |
Why?
|
Apolipoprotein E4 | 1 | 2022 | 708 | 0.040 |
Why?
|
Area Under Curve | 1 | 2021 | 1638 | 0.040 |
Why?
|
Cross-Linking Reagents | 1 | 2020 | 687 | 0.040 |
Why?
|
Administration, Topical | 1 | 2019 | 704 | 0.040 |
Why?
|
Keratoplasty, Penetrating | 1 | 2018 | 144 | 0.040 |
Why?
|
Neonatal Screening | 1 | 2022 | 597 | 0.040 |
Why?
|
Smad1 Protein | 1 | 2017 | 81 | 0.040 |
Why?
|
Protein Isoforms | 1 | 2022 | 1699 | 0.030 |
Why?
|
Research Design | 1 | 2013 | 6180 | 0.030 |
Why?
|
Tetradecanoylphorbol Acetate | 1 | 1998 | 817 | 0.030 |
Why?
|
Thioredoxin Reductase 2 | 1 | 2016 | 25 | 0.030 |
Why?
|
Child, Preschool | 3 | 2016 | 42230 | 0.030 |
Why?
|
Persistent Hyperplastic Primary Vitreous | 1 | 2016 | 7 | 0.030 |
Why?
|
Clinical Trials as Topic | 1 | 2012 | 8002 | 0.030 |
Why?
|
Growth Differentiation Factors | 1 | 2017 | 100 | 0.030 |
Why?
|
Pemphigoid, Benign Mucous Membrane | 1 | 2017 | 113 | 0.030 |
Why?
|
Survival Rate | 1 | 2010 | 12725 | 0.030 |
Why?
|
Species Specificity | 1 | 2020 | 2414 | 0.030 |
Why?
|
Apolipoproteins E | 1 | 2022 | 1444 | 0.030 |
Why?
|
Cytosol | 1 | 1999 | 888 | 0.030 |
Why?
|
Cricetulus | 1 | 2017 | 814 | 0.030 |
Why?
|
Sensory Thresholds | 1 | 2017 | 377 | 0.030 |
Why?
|
Sulfur Hexafluoride | 1 | 2015 | 26 | 0.030 |
Why?
|
Virion | 1 | 2017 | 422 | 0.030 |
Why?
|
Ophthalmoscopes | 1 | 2015 | 20 | 0.030 |
Why?
|
Delayed-Action Preparations | 1 | 2019 | 962 | 0.030 |
Why?
|
Fenofibrate | 1 | 2016 | 87 | 0.030 |
Why?
|
Perioperative Period | 1 | 2017 | 250 | 0.030 |
Why?
|
Ultraviolet Rays | 1 | 2020 | 1080 | 0.030 |
Why?
|
Bayes Theorem | 1 | 2023 | 2330 | 0.030 |
Why?
|
Epidermal Growth Factor | 1 | 1998 | 701 | 0.030 |
Why?
|
CHO Cells | 1 | 2017 | 1387 | 0.030 |
Why?
|
Photography | 1 | 2018 | 532 | 0.030 |
Why?
|
Cattle | 1 | 2020 | 3849 | 0.030 |
Why?
|
Amacrine Cells | 1 | 2014 | 52 | 0.030 |
Why?
|
Retinal Bipolar Cells | 1 | 2014 | 46 | 0.030 |
Why?
|
Refraction, Ocular | 1 | 2015 | 184 | 0.030 |
Why?
|
Pigment Epithelium of Eye | 1 | 2014 | 209 | 0.030 |
Why?
|
Estrogen Antagonists | 1 | 2014 | 150 | 0.030 |
Why?
|
Pregnancy | 1 | 2016 | 29874 | 0.030 |
Why?
|
Arachidonic Acids | 1 | 2014 | 294 | 0.030 |
Why?
|
Cohort Studies | 3 | 2024 | 41487 | 0.030 |
Why?
|
Superoxide Dismutase | 1 | 2016 | 594 | 0.030 |
Why?
|
MAP Kinase Signaling System | 1 | 2001 | 1486 | 0.030 |
Why?
|
Sequence Alignment | 1 | 1998 | 2180 | 0.030 |
Why?
|
Evoked Potentials, Visual | 1 | 2016 | 417 | 0.030 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2013 | 15936 | 0.030 |
Why?
|
Random Allocation | 1 | 2017 | 2395 | 0.030 |
Why?
|
Cloning, Molecular | 1 | 1998 | 4174 | 0.030 |
Why?
|
Rats, Sprague-Dawley | 3 | 1999 | 8181 | 0.020 |
Why?
|
Energy Intake | 1 | 2020 | 2134 | 0.020 |
Why?
|
Dietary Fats | 1 | 2020 | 1995 | 0.020 |
Why?
|
Biopsy | 1 | 2024 | 6766 | 0.020 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2017 | 1334 | 0.020 |
Why?
|
Tomography, X-Ray Computed | 1 | 2015 | 20570 | 0.020 |
Why?
|
DNA Mutational Analysis | 1 | 2020 | 4111 | 0.020 |
Why?
|
Quinolines | 1 | 2017 | 764 | 0.020 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2001 | 2425 | 0.020 |
Why?
|
Light Coagulation | 1 | 2011 | 72 | 0.020 |
Why?
|
Lasers, Semiconductor | 1 | 2011 | 41 | 0.020 |
Why?
|
Macrophages, Peritoneal | 1 | 2012 | 238 | 0.020 |
Why?
|
PPAR gamma | 1 | 2014 | 484 | 0.020 |
Why?
|
Drug Therapy, Combination | 2 | 2013 | 6310 | 0.020 |
Why?
|
Immunoblotting | 1 | 2014 | 1646 | 0.020 |
Why?
|
Mutation, Missense | 1 | 2020 | 2571 | 0.020 |
Why?
|
Immunosuppressive Agents | 1 | 2004 | 4174 | 0.020 |
Why?
|
DNA, Complementary | 1 | 2014 | 1991 | 0.020 |
Why?
|
Rhodamines | 1 | 2011 | 178 | 0.020 |
Why?
|
Ocular Hypertension | 1 | 2012 | 209 | 0.020 |
Why?
|
Quercetin | 1 | 2011 | 97 | 0.020 |
Why?
|
Internationality | 1 | 2016 | 1001 | 0.020 |
Why?
|
Antibodies, Blocking | 1 | 2011 | 243 | 0.020 |
Why?
|
Chromatography, Liquid | 1 | 2014 | 983 | 0.020 |
Why?
|
Pilot Projects | 1 | 2024 | 8631 | 0.020 |
Why?
|
Aldehydes | 1 | 2011 | 170 | 0.020 |
Why?
|
Substrate Specificity | 1 | 2014 | 1791 | 0.020 |
Why?
|
Mass Spectrometry | 1 | 2017 | 2192 | 0.020 |
Why?
|
Diterpenes | 1 | 2011 | 171 | 0.020 |
Why?
|
Neuronal Plasticity | 1 | 2018 | 1436 | 0.020 |
Why?
|
Retreatment | 1 | 2011 | 598 | 0.020 |
Why?
|
Treatment Failure | 1 | 2015 | 2645 | 0.020 |
Why?
|
Fatty Acids | 1 | 1997 | 1808 | 0.020 |
Why?
|
Alleles | 1 | 2020 | 6863 | 0.020 |
Why?
|
HIV Infections | 1 | 2015 | 17351 | 0.020 |
Why?
|
Citrates | 2 | 2000 | 134 | 0.020 |
Why?
|
Malates | 2 | 1999 | 34 | 0.020 |
Why?
|
Genes, Dominant | 1 | 2011 | 852 | 0.020 |
Why?
|
Databases, Factual | 1 | 2024 | 7967 | 0.020 |
Why?
|
Combined Modality Therapy | 2 | 2011 | 8529 | 0.020 |
Why?
|
Anterior Eye Segment | 1 | 2009 | 143 | 0.020 |
Why?
|
Tandem Mass Spectrometry | 1 | 2014 | 1188 | 0.020 |
Why?
|
Osmolar Concentration | 2 | 1999 | 659 | 0.020 |
Why?
|
Endoscopy | 1 | 2017 | 1851 | 0.020 |
Why?
|
Sequence Analysis, DNA | 1 | 1998 | 4740 | 0.020 |
Why?
|
Pyrazoles | 1 | 2017 | 2009 | 0.020 |
Why?
|
Cell Movement | 1 | 2018 | 5203 | 0.020 |
Why?
|
Life Style | 1 | 2018 | 3917 | 0.020 |
Why?
|
Injections | 1 | 2009 | 830 | 0.020 |
Why?
|
Plasmids | 1 | 2011 | 2269 | 0.020 |
Why?
|
Ophthalmologic Surgical Procedures | 1 | 2009 | 354 | 0.020 |
Why?
|
Green Fluorescent Proteins | 1 | 2011 | 2065 | 0.020 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 2020 | 3415 | 0.020 |
Why?
|
Alcohol Drinking | 1 | 2018 | 4028 | 0.020 |
Why?
|
Anesthesia | 1 | 2016 | 1594 | 0.020 |
Why?
|
Pyrimidines | 1 | 2017 | 3028 | 0.020 |
Why?
|
Synapses | 1 | 2014 | 1769 | 0.010 |
Why?
|
Bone Marrow Transplantation | 1 | 2012 | 2693 | 0.010 |
Why?
|
Imaging, Three-Dimensional | 1 | 2017 | 4063 | 0.010 |
Why?
|
Leukocytes | 1 | 2012 | 2026 | 0.010 |
Why?
|
Infusions, Intravenous | 1 | 2009 | 2219 | 0.010 |
Why?
|
Animals, Genetically Modified | 1 | 2009 | 1561 | 0.010 |
Why?
|
Comorbidity | 1 | 2018 | 10508 | 0.010 |
Why?
|
Logistic Models | 1 | 2018 | 13255 | 0.010 |
Why?
|
Computer Simulation | 1 | 2016 | 6240 | 0.010 |
Why?
|
Diet | 1 | 2020 | 8075 | 0.010 |
Why?
|
Mutation | 2 | 2020 | 30052 | 0.010 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2016 | 3245 | 0.010 |
Why?
|
Body Mass Index | 1 | 2018 | 12953 | 0.010 |
Why?
|
Threonine | 1 | 2001 | 271 | 0.010 |
Why?
|
Endothelium, Vascular | 1 | 2012 | 4431 | 0.010 |
Why?
|
14-3-3 Proteins | 1 | 2001 | 220 | 0.010 |
Why?
|
Tyrosine 3-Monooxygenase | 1 | 2001 | 370 | 0.010 |
Why?
|
Muscle Denervation | 1 | 1999 | 60 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2017 | 15842 | 0.010 |
Why?
|
Starvation | 1 | 1999 | 142 | 0.010 |
Why?
|
Carnitine O-Palmitoyltransferase | 1 | 1998 | 82 | 0.010 |
Why?
|
Acetoacetates | 1 | 1997 | 19 | 0.010 |
Why?
|
Serine | 1 | 2001 | 830 | 0.010 |
Why?
|
Receptor, Insulin | 1 | 2001 | 835 | 0.010 |
Why?
|
Rodentia | 1 | 1997 | 262 | 0.010 |
Why?
|
Biopolymers | 1 | 1996 | 184 | 0.010 |
Why?
|
Tacrolimus Binding Proteins | 1 | 1996 | 194 | 0.010 |
Why?
|
Rats, Wistar | 1 | 1999 | 1848 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2011 | 9420 | 0.010 |
Why?
|
Food | 1 | 1999 | 774 | 0.010 |
Why?
|
Oxygen Consumption | 1 | 2000 | 1866 | 0.010 |
Why?
|
Insulin | 2 | 1999 | 6596 | 0.010 |
Why?
|
Kinetics | 1 | 2000 | 6374 | 0.010 |
Why?
|
Heat-Shock Proteins | 1 | 1996 | 795 | 0.010 |
Why?
|
United States | 1 | 2020 | 72334 | 0.010 |
Why?
|
Cell Membrane | 1 | 2001 | 3688 | 0.010 |
Why?
|
Transfection | 1 | 1996 | 5774 | 0.000 |
Why?
|
Obesity | 1 | 1999 | 12947 | 0.000 |
Why?
|